US Patent 7696198 Phosphodiesterase 4 inhibitors
Patent 7696198 was granted and assigned to Memory Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+321 characters)
Article
Patent abstract
Selective PDE4 inhibition is achieved by 4-(substituted-phenyl)-2-pyrrolidinone compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds like rolipram and show selectivity with regard to inhibition of other classes of PDEs. The compounds of the present invention are of formula I:
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Allen Hopper0
Ashok Tehim0
Erik Kuester0
Robert F. Dunn0
Ruiping Liu0
Thomas E. Renau0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07696198 Phosphodiesterase 4 inhibitors US Patent 7696198 Phosphodiesterase 4 inhibitors
Infobox
Patent Number
076961980
Patent Number
76961980
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076961980
Date of Patent
April 13, 2010
0Patent Application Number
108256100
Date Filed
April 16, 2004
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07696198 Phosphodiesterase 4 inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07696198
Date of patent
April 13, 2010
Patent application number
10825610
Date Filed
April 16, 2004
Patent primary examiner
Find more entities like US Patent 7696198 Phosphodiesterase 4 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.